PBM Reform 2026: What Recent Legislation Means for the Industry

Mar
17
2026

Date: March 17, 2026

Time: 12:30PM - 1:30PM (EST)

Location: Virtual

The pharmacy benefit manager (PBM) landscape is undergoing significant regulatory transformation, with a wave of developments signaling a new era of transparency and accountability for PBMs and the entities that contract with them. In early 2026 alone, Congress passed landmark PBM reforms in the Consolidated Appropriations Act of 2026, the Department of Labor (DOL) proposed new rules for group health plans’ relationships with PBMs, the FTC has settled enforcement actions, and the Trump administration launched TrumpRx.gov as part of its broader drug pricing initiatives.

Join attorneys from our Health Law practice for a practical discussion on what these changes mean for your organization. We will break down the key provisions of the CAA 2026 PBM reforms, explore the DOL’s proposed rule and its implications for plan sponsors and PBMs, examine recent FTC settlements, and assess how the administration’s drug pricing initiatives may shape the market going forward.

Attendees will come away ready to:

  • Prioritize compliance efforts based on the CAA 2026 PBM reform provisions and key timelines
  • Monitor the DOL’s proposed rule and prepare for its potential impact on PBM–plan sponsor relationships
  • Discuss and, if necessary, implement operational changes aligned with the standards set by recent FTC settlements
  • Position their organizations for growth amid ongoing regulatory change
  • Who should attend: PBMs, health plans, pharmaceutical manufacturers, pharmacies, rebate aggregators, and investors in the health care space.

This webinar will help you prioritize, implement, and monitor these new requirements without disrupting your current operations — and position your organization for future growth in an evolving regulatory environment.

Register for Event

Speakers

Theresa C. Carnegie

Theresa C. Carnegie

Theresa advises clients on all aspects of the pharmaceutical supply chain, including counseling industry stakeholders on a range of business, legal, transactional, and compliance matters. She provides clients with strategic counseling and creative business modeling that considers legal restrictions and regulatory risk in light of innovation and business goals.
Bridgette A. Keller

Bridgette A. Keller

Bridgette advises health care providers, ACOs, health plans, PBMs, and laboratories on regulatory, fraud and abuse, and business planning matters, applying her experience in health system administration and ethics in health care to her health law practice.
Hassan Shaikh

Hassan Shaikh

Hassan advises a broad range of clients across the health care industry—including health care systems, pharmacies, and private equity firms investing in health care companies—in complex industry transactions and compliance and regulatory matters.